PROCÉDÉ D'EXPLOITATION DE LÉTALITÉ SYNTHÉTIQUE BASÉE SUR LA SUREXPRESSION D'ONCOGÈNE MYC

• 收藏
• 分享

专利权人:

Ltd.;Chengdu Anticancer Bioscience

发明人:

ZHANG, Jing,ZHANG, Shenqiu,YANG, Dun

申请号：

EP18813239

公开号：

EP3500263A4

申请日:

2018.06.04

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

The present invention generally relates to inhibitor compounds and their use to selectively kill a class of cancer cells. Methods and means related to the treatment of cancers which overexpress the MYC family of oncogenes using Rho-associated protein kinase inhibitors, such as dimethylfasudil, which have shown to elicit cellular apoptosis, are provided herein.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/